Viatris Inc (NAS:VTRS)
$ 11.62 0 (0%) Market Cap: 13.87 Bil Enterprise Value: 30.11 Bil PE Ratio: 0 PB Ratio: 0.71 GF Score: 71/100

Viatris Inc at BofA Securities 2021 Health Care Conference Transcript

May 11, 2021 / 12:00PM GMT
Release Date Price: $15.14 (+0.66%)
Jason Matthew Gerberry
BofA Securities, Research Division - MD in US Equity Research

Thanks, operator, and good morning, everybody. Thanks for joining us at the Bank of America's Annual Healthcare Conference, which is being held virtually for the second year in a row rather than Las Vegas, but hopefully, this is the final year of virtual get-togethers. I'm pleased to be kicking-off the conference with Viatris. We're joined by Rajiv Malik, President; and Sanjeev Narula, CFO. So Viatris just reported its first full quarter as a combined merged entity, which previously was Mylan and Pfizer's Upjohn. So gentlemen, thanks so much for joining us after your first full quarter and all the exciting updates yesterday.

Rajiv Malik;Sanjeev Narula
Viatris Inc. - President & Executive Director;Viatris

Good morning, Jason, and very excited to join you today this morning about this conference. We are very excited especially, after the first quarter, which you all see. We are very -- we as management, we as a team, are very pleased with.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot